Brad D. Smith - Jun 28, 2024 Form 4 Insider Report for HUMANA INC (HUM)

Role
Director
Signature
Brad D. Smith
Stock symbol
HUM
Transactions as of
Jun 28, 2024
Transactions value $
$31,860
Form type
4
Date filed
7/2/2024, 09:54 AM
Previous filing
Apr 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding HUM Humana Common 386 Jun 28, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Restricted Stock Units +Grant/Award $31,860 +84 +23.73% $379.29 438 Jun 28, 2024 Humana Common 84 Direct F2
holding HUM Restricted Stock Units 380 Jun 28, 2024 Humana Common 380 Direct F1
holding HUM Restricted Stock Units 3 Jun 28, 2024 Humana Common 3 Direct F3
holding HUM Restricted Stock Units 430 Jun 28, 2024 Humana Common 430 Direct F4

Explanation of Responses:

Id Content
F1 Annual Director's fee payable in stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F2 Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F3 Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F4 Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.